Insmed Rg
INSM
USD
STOCK MARKET:
NMS
Closed
 
...
Large gap with delayed quotes
Last quote
07/18/2026 - 02:00:00
Bid
07/17/2026 - 21:59:59
Bid
Volume
Ask
07/17/2026 - 21:59:59
Ask
Volume
108.32
+0.86 ( +0.80% )
108.31
100
108.33
2,300
More information
Analysis by TheScreener
17.07.2026
Evaluation Neutral  
Interest Strong  
Sensibility High  
Analysis date: 17.07.2026
Global Evaluation
  Neutral
The stock is classified in the neutral zone since 07.07.2026.
Interest
  Strong
Three stars since 07.07.2026.
Earnings Rev Trend
  Negative
 
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 29.05.2026 at a price of 106.91.
Evaluation
  Strongly undervalued
 
Based on its growth potential and our own criteria, we believe the share price is currently undervalued.
MT Tech Trend
  Neutral
 
The stock is currently trading close to its dividend-adjusted forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this, the stock traded above its moving average since 07.07.2026.
4wk Rel Perf
  14.12%
 
The four-week dividend-adjusted overperformance versus SP500 is 14.12%.
Sensibility
  High
The stock has been on the high-sensitivity level since 19.12.2025.
Bear Market Factor
  Low
On average, the stock has a tendency to minimize the drops in the index by -0.62%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 4.62%.
Mkt Cap in $bn
  23.29
With a market capitalization >$8bn, INSMED is considered a large-cap stock.
G/PE Ratio
  1.55
A "Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings" ratio higher than 1.5 indicates that the stock's price presents a discount to growth >40% in this case.
LT P/E
  37.11
The estimated PE is for the year 2028.
LT Growth
  57.44%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
  20
Over the last seven weeks, an average of 20 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  2
For 1% of index variation, the stock varies on average by 0.02%.
Correlation
  0
Stock movements are totally independent of index variations.
Value at Risk
  28.69
The value at risk is estimated at USD 28.69. The risk is therefore 26.48%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  16.09.2014